Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.

Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study

NCT05430854 ·Status: TERMINATED ·Phase: PHASE2

Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial)

NCT05590390 ·Status: ACTIVE_NOT_RECRUITING

Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

NCT05540665 ·Status: TERMINATED ·Phase: PHASE2

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

NCT03138941 ·Status: RECRUITING

A Study of DS-7011a in Patients With Systemic Lupus Erythematosus

NCT05638802 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02446912 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus

NCT03451422 ·Status: COMPLETED ·Phase: PHASE1

Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02794285 ·Status: COMPLETED ·Phase: PHASE3

An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT04810754 ·Status: UNKNOWN ·Phase: PHASE2

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

NCT00000421 ·Status: COMPLETED ·Phase: PHASE2

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

NCT05138133 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus

NCT00004795 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT04294667 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

NCT02725515 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus

NCT02804763 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

NCT01135459 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

NCT04976322 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

NCT03845517 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

NCT02547922 ·Status: COMPLETED ·Phase: PHASE2

A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

NCT05203692 ·Status: COMPLETED ·Phase: PHASE1

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

NCT06133972 ·Status: RECRUITING ·Phase: PHASE3

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

NCT07332481 ·Status: RECRUITING ·Phase: PHASE3

The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus

NCT00797784 ·Status: UNKNOWN ·Phase: PHASE2

Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

NCT06046534 ·Status: COMPLETED

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

NCT05268289 ·Status: RECRUITING ·Phase: PHASE2